Annual Cash & Cash Equivalents
$1.27 M
+$356.00 K+38.91%
October 1, 2024
Summary
- As of February 8, 2025, ANIX annual cash & cash equivalents is $1.27 million, with the most recent change of +$356.00 thousand (+38.91%) on October 1, 2024.
- During the last 3 years, ANIX annual cash & cash equivalents has fallen by -$27.86 million (-95.64%).
- ANIX annual cash & cash equivalents is now -95.64% below its all-time high of $29.13 million, reached on October 31, 2021.
Performance
ANIX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$1.27 M
+$46.00 K+3.76%
October 1, 2024
Summary
- As of February 8, 2025, ANIX quarterly cash and cash equivalents is $1.27 million, with the most recent change of +$46.00 thousand (+3.76%) on October 1, 2024.
- Over the past year, ANIX quarterly cash and cash equivalents has increased by +$356.00 thousand (+38.91%).
- ANIX quarterly cash and cash equivalents is now -95.73% below its all-time high of $29.78 million, reached on January 31, 2022.
Performance
ANIX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ANIX Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +38.9% | +38.9% |
| 3 y3 years | -95.6% | -60.3% |
| 5 y5 years | -63.6% | -60.3% |
ANIX Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -95.6% | +38.9% | -95.7% | +38.9% |
| 5 y | 5-year | -95.6% | +38.9% | -95.7% | +38.9% |
| alltime | all time | -95.6% | +274.1% | -95.7% | +1152.2% |
Anixa Biosciences Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Oct 2024 | $1.27 M(+38.9%) | $1.27 M(+3.8%) |
| Jul 2024 | - | $1.23 M(+23.1%) |
| Apr 2024 | - | $995.00 K(-0.3%) |
| Jan 2024 | - | $998.00 K(+9.1%) |
| Oct 2023 | $915.00 K(-92.6%) | $915.00 K(-71.4%) |
| Jul 2023 | - | $3.20 M(-43.1%) |
| Apr 2023 | - | $5.62 M(-42.6%) |
| Jan 2023 | - | $9.79 M(-20.8%) |
| Oct 2022 | $12.36 M(-57.6%) | $12.36 M(-49.0%) |
| Jul 2022 | - | $24.25 M(-12.5%) |
| Apr 2022 | - | $27.73 M(-6.9%) |
| Jan 2022 | - | $29.78 M(+2.2%) |
| Oct 2021 | $29.13 M(+353.9%) | $29.13 M(+7.0%) |
| Jul 2021 | - | $27.22 M(-1.7%) |
| Apr 2021 | - | $27.70 M(+131.2%) |
| Jan 2021 | - | $11.98 M(+86.7%) |
| Oct 2020 | $6.42 M(+83.8%) | $6.42 M(+8.3%) |
| Jul 2020 | - | $5.93 M(+105.2%) |
| Apr 2020 | - | $2.89 M(+2.3%) |
| Jan 2020 | - | $2.82 M(-19.2%) |
| Oct 2019 | $3.49 M(+14.3%) | $3.49 M(-20.6%) |
| Jul 2019 | - | $4.40 M(+15.0%) |
| Apr 2019 | - | $3.82 M(-8.0%) |
| Jan 2019 | - | $4.15 M(+35.9%) |
| Oct 2018 | $3.06 M(-8.5%) | $3.06 M(+17.9%) |
| Jul 2018 | - | $2.59 M(-37.9%) |
| Apr 2018 | - | $4.17 M(+46.6%) |
| Jan 2018 | - | $2.85 M(-14.7%) |
| Oct 2017 | $3.34 M(+34.2%) | $3.34 M(+82.1%) |
| Jul 2017 | - | $1.83 M(-36.3%) |
| Apr 2017 | - | $2.88 M(+105.5%) |
| Jan 2017 | - | $1.40 M(-43.7%) |
| Oct 2016 | $2.49 M(-43.0%) | $2.49 M(+21.4%) |
| Jul 2016 | - | $2.05 M(-21.6%) |
| Apr 2016 | - | $2.61 M(-34.4%) |
| Jan 2016 | - | $3.98 M(-8.9%) |
| Oct 2015 | $4.37 M(+30.0%) | $4.37 M(-15.3%) |
| Jul 2015 | - | $5.16 M(-15.1%) |
| Apr 2015 | - | $6.08 M(-22.1%) |
| Jan 2015 | - | $7.81 M(+132.3%) |
| Oct 2014 | $3.36 M(+274.2%) | $3.36 M(-8.0%) |
| Jul 2014 | - | $3.65 M(+491.2%) |
| Apr 2014 | - | $617.70 K(-20.4%) |
| Jan 2014 | - | $776.10 K(-13.6%) |
| Oct 2013 | $898.20 K(+164.4%) | $898.20 K(-8.5%) |
| Jul 2013 | - | $982.00 K(-22.9%) |
| Apr 2013 | - | $1.27 M(-25.7%) |
| Jan 2013 | - | $1.71 M(+404.4%) |
| Oct 2012 | $339.70 K(-56.1%) | $339.70 K(+234.7%) |
| Jul 2012 | - | $101.50 K(-22.3%) |
| Apr 2012 | - | $130.70 K(-71.8%) |
| Jan 2012 | - | $463.00 K(-40.2%) |
| Oct 2011 | $774.00 K(-29.3%) | $774.00 K(+40.4%) |
| Jul 2011 | - | $551.40 K(+58.9%) |
| Apr 2011 | - | $347.10 K(-64.5%) |
| Jan 2011 | - | $979.00 K(-10.5%) |
| Oct 2010 | $1.09 M(-24.6%) | $1.09 M(-22.3%) |
| Jul 2010 | - | $1.41 M(+31.1%) |
| Apr 2010 | - | $1.07 M(-10.2%) |
| Jan 2010 | - | $1.20 M(-17.5%) |
| Oct 2009 | $1.45 M(+203.2%) | $1.45 M(+352.4%) |
| Jul 2009 | - | $320.80 K(-75.2%) |
| Apr 2009 | - | $1.29 M(-24.8%) |
| Jan 2009 | - | $1.72 M(+258.5%) |
| Oct 2008 | $478.60 K(-28.5%) | $478.60 K(+4.6%) |
| Jul 2008 | - | $457.50 K(-40.1%) |
| Apr 2008 | - | $763.80 K(-3.8%) |
| Jan 2008 | - | $793.60 K(+18.6%) |
| Oct 2007 | $669.10 K(-47.8%) | $669.10 K(+2.5%) |
| Jul 2007 | - | $652.80 K(-14.8%) |
| Apr 2007 | - | $766.00 K(-7.5%) |
| Jan 2007 | - | $828.00 K(-35.4%) |
| Oct 2006 | $1.28 M | $1.28 M(+109.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jul 2006 | - | $611.30 K(-16.5%) |
| Apr 2006 | - | $732.00 K(-9.5%) |
| Jan 2006 | - | $809.10 K(+59.7%) |
| Oct 2005 | $506.50 K(-49.5%) | $506.50 K(-12.9%) |
| Jul 2005 | - | $581.80 K(-9.2%) |
| Apr 2005 | - | $640.60 K(-36.7%) |
| Jan 2005 | - | $1.01 M(+0.9%) |
| Oct 2004 | $1.00 M(-2.0%) | $1.00 M(-3.6%) |
| Jul 2004 | - | $1.04 M(-16.3%) |
| Apr 2004 | - | $1.24 M(+43.2%) |
| Jan 2004 | - | $868.20 K(-15.2%) |
| Oct 2003 | $1.02 M(+19.7%) | $1.02 M(-3.1%) |
| Jul 2003 | - | $1.06 M(+159.1%) |
| Apr 2003 | - | $407.80 K(-32.4%) |
| Jan 2003 | - | $602.90 K(-29.5%) |
| Oct 2002 | $854.80 K(-35.1%) | $854.80 K(-34.3%) |
| Jul 2002 | - | $1.30 M(-39.2%) |
| Apr 2002 | - | $2.14 M(-38.0%) |
| Jan 2002 | - | $3.45 M(+162.4%) |
| Oct 2001 | $1.32 M(+16.1%) | $1.32 M(-34.7%) |
| Jul 2001 | - | $2.02 M(+1176.4%) |
| Apr 2001 | - | $157.90 K(-77.5%) |
| Jan 2001 | - | $703.10 K(-38.0%) |
| Oct 2000 | $1.13 M(-29.1%) | $1.13 M(-56.7%) |
| Jul 2000 | - | $2.62 M(-27.0%) |
| Apr 2000 | - | $3.59 M(+70.9%) |
| Jan 2000 | - | $2.10 M(+31.3%) |
| Oct 1999 | $1.60 M(-70.4%) | $1.60 M(-30.4%) |
| Jul 1999 | - | $2.30 M(-37.8%) |
| Apr 1999 | - | $3.70 M(-15.9%) |
| Jan 1999 | - | $4.40 M(-18.5%) |
| Oct 1998 | $5.40 M(-56.1%) | $5.40 M(-11.5%) |
| Jul 1998 | - | $6.10 M(-23.8%) |
| Apr 1998 | - | $8.00 M(-28.6%) |
| Jan 1998 | - | $11.20 M(-8.9%) |
| Oct 1997 | $12.30 M(-44.6%) | $12.30 M(-22.2%) |
| Jul 1997 | - | $15.80 M(-14.6%) |
| Apr 1997 | - | $18.50 M(-5.1%) |
| Jan 1997 | - | $19.50 M(-12.2%) |
| Oct 1996 | $22.20 M(+149.4%) | $22.20 M(+3.7%) |
| Jul 1996 | - | $21.40 M(+54.0%) |
| Apr 1996 | - | $13.90 M(+36.3%) |
| Jan 1996 | - | $10.20 M(+14.6%) |
| Oct 1995 | $8.90 M(+43.5%) | $8.90 M(+2.3%) |
| Jul 1995 | - | $8.70 M(+26.1%) |
| Apr 1995 | - | $6.90 M(+21.1%) |
| Jan 1995 | - | $5.70 M(-8.1%) |
| Oct 1994 | $6.20 M(-25.3%) | $6.20 M(-11.4%) |
| Jul 1994 | - | $7.00 M(+2.9%) |
| Apr 1994 | - | $6.80 M(-8.1%) |
| Jan 1994 | - | $7.40 M(-10.8%) |
| Oct 1993 | $8.30 M(+102.4%) | $8.30 M(+9.2%) |
| Jul 1993 | - | $7.60 M(+31.0%) |
| Apr 1993 | - | $5.80 M(+7.4%) |
| Jan 1993 | - | $5.40 M(+31.7%) |
| Oct 1992 | $4.10 M(0.0%) | $4.10 M(0.0%) |
| Jul 1992 | - | $4.10 M(-4.7%) |
| Apr 1992 | - | $4.30 M(0.0%) |
| Jan 1992 | - | $4.30 M(+4.9%) |
| Oct 1991 | $4.10 M(+95.2%) | $4.10 M(+95.2%) |
| Jul 1991 | - | $2.10 M(-30.0%) |
| Apr 1991 | - | $3.00 M(+42.9%) |
| Jan 1991 | - | $2.10 M(0.0%) |
| Oct 1990 | $2.10 M(-4.5%) | $2.10 M(-4.5%) |
| Jul 1990 | - | $2.20 M(+29.4%) |
| Apr 1990 | - | $1.70 M(-32.0%) |
| Jan 1990 | - | $2.50 M(+13.6%) |
| Oct 1989 | $2.20 M(+29.4%) | $2.20 M(+29.4%) |
| Oct 1988 | $1.70 M(+142.9%) | $1.70 M(+142.9%) |
| Oct 1987 | $700.00 K(-30.0%) | $700.00 K(-30.0%) |
| Oct 1986 | $1.00 M(-64.3%) | $1.00 M(-64.3%) |
| Oct 1985 | $2.80 M(-26.3%) | $2.80 M(-26.3%) |
| Oct 1984 | $3.80 M | $3.80 M |
FAQ
- What is Anixa Biosciences annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Anixa Biosciences?
- What is Anixa Biosciences annual cash & cash equivalents year-on-year change?
- What is Anixa Biosciences quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Anixa Biosciences?
- What is Anixa Biosciences quarterly cash and cash equivalents year-on-year change?
What is Anixa Biosciences annual cash & cash equivalents?
The current annual cash & cash equivalents of ANIX is $1.27 M
What is the all time high annual cash & cash equivalents for Anixa Biosciences?
Anixa Biosciences all-time high annual cash & cash equivalents is $29.13 M
What is Anixa Biosciences annual cash & cash equivalents year-on-year change?
Over the past year, ANIX annual cash & cash equivalents has changed by +$356.00 K (+38.91%)
What is Anixa Biosciences quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ANIX is $1.27 M
What is the all time high quarterly cash and cash equivalents for Anixa Biosciences?
Anixa Biosciences all-time high quarterly cash and cash equivalents is $29.78 M
What is Anixa Biosciences quarterly cash and cash equivalents year-on-year change?
Over the past year, ANIX quarterly cash and cash equivalents has changed by +$356.00 K (+38.91%)